axicabtagene ciloleucel,tisagenlecleucel
gilead,novartis,daiichi sankyo
['descar-t', 'axi-cel', 'tisa-cel', 'lymsm', 'lymphoma']
congress| #ash22 federico erbella, delivers results on pts with r/r aggressive b-cell #lymphoma from the descar-t registry who had late failures of car-t therapies. data showed dismal outcomes amongst this patient subset #lymsm #medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm